NCT02805686View on ClinicalTrials.gov

" En Face OCT's Contribution in the Detection of Macular Retinal Toxicity Signs Linked to the Chronic Treatment of Synthetic Antimalarials"

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Maculopathy
Interventions
DEVICE

spectral domain optical coherence tomography

DEVICE

multifocal electroretinogram

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT02805686 - " En Face OCT's Contribution in the Detection of Macular Retinal Toxicity Signs Linked to the Chronic Treatment of Synthetic Antimalarials" | Biotech Hunter | Biotech Hunter